De Novo Femoropopliteal stenoses: Endovascular Gamma Irradiation Following Angioplasty-Angiographic and Clinical Follow-up in a Prospective Randomized Controlled Trial

Abstract

The authors studied the results of a randomized controlled trial in which patients who underwent percutaneous transluminal angioplasty either received centered endovascular gamma irradiation or were in a control group. Patients were evaluated at various time-points with intra-arterial angiography, duplex ultrasonography, treadmill tests, and were also interviewed and the results were analyzed. At baseline the two groups had similar characteristics. The rates of target lesion restenosis at 6 and 12 months were significantly lower in the irradiation group. The authors concluded that patients who had endovascular irradiation after angioplasty of de novo femoropopliteal stenosis had a significantly reduced degree of stenosis at 6 and 12. Target vessel retreatment was more frequent in the irradiation group.

Keywords

endovascular gamma irradiation angoplasty femoropopliteal stenosis

Get full access to this article

View all access options for this article.

References

1. Hansrani M , Overbeck K , Smout J , Stansby G : Intravascular brachytherapy: a systematic review of its role in reducing restenosis after endovascular treatment in peripheral arterial disease. Eur J Vasc Endovasc Surg 2002; 24:377-382.

2. Krueger K , Landwehr P , Lackner K , et al: Endovascular gamma irradiation of femoropopliteal de novo stenoses immediately after PTA: interim results of a prospective randomized controlled trial. Radiology 224:519-528, 2002.

3. Minar E , Potter R , Maca T , et al: Endovascular brachytherapy for prophylaxis of restenosis after femroropopliteal angioplasty. Circulation 102:2694-2699, 2000.

4. Pokrajac B , Potter R , Maca R , et al: Brachytherapy for prophylaxis of restenosis after femoropopliteal percutaneous transluminal angioplasty: the prospective randomized Vienna-2 Trial. Radiotherapy, parameters, and risk factors analysis. Int J Radiat Oncol Biol Phys 48: 923-931, 2000.

5. Grise A , Massullo V , Teirstein P , et al: Five-year clinical follow-up after intracoronary radiation: results of a randomized clinical trial. Circulation 105:2737-2740, 2002.

6. Duda SH , Pusich B , Richter G. et al: Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation 106:1505-1509, 2002.